These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23210976)

  • 1. Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
    Goldust M; Ranjkesh MR; Amirinia M; Golforoushan F; Rezaee E; Rezazadeh Saatlou MA
    J Dermatolog Treat; 2013 Feb; ():. PubMed ID: 23210976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Masoudnia S; Raghifar R
    Ann Parasitol; 2013; 59(3):119-23. PubMed ID: 24881281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream.
    Goldust M; Rezaee E; Raghifar R; Hemayat S
    Ann Parasitol; 2013; 59(2):73-7. PubMed ID: 24171300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Rouhani S
    Ann Parasitol; 2013; 59(1):25-9. PubMed ID: 23829055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of seborrheic dermatitis: comparison of sertaconazole 2 % cream versus pimecrolimus 1 % cream.
    Goldust M; Rezaee E; Raghifar R
    Ir J Med Sci; 2013 Dec; 182(4):703-6. PubMed ID: 23715821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Raghifar R
    Ann Parasitol; 2013; 59(4):173-7. PubMed ID: 24791343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of seborrheic dermatitis, comparison of sertaconazole 2% cream versus ketoconazole 2% cream.
    Lotti T; Goldust M; Rezaee E
    J Dermatolog Treat; 2013 May; ():. PubMed ID: 23441833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial.
    Balighi K; Ghodsi SZ; Daneshpazhooh M; Ghale-Baghi S; Nasimi M; Azizpour A
    Int J Womens Dermatol; 2017 Jun; 3(2):107-110. PubMed ID: 28560305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis.
    Georgescu SR; Mitran CI; Mitran MI; Amuzescu A; Matei C; Tampa M
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sertaconazole 2% cream versus hydrocortisone 1% ointment in the treatment of atopic dermatitis.
    Saki N; Jowkar F; Alyaseen S
    J Dermatolog Treat; 2013 Dec; 24(6):447-9. PubMed ID: 23470235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial.
    Azizzadeh M; Pahlevan D; Bagheri B
    Clin Exp Dermatol; 2022 May; 47(5):926-931. PubMed ID: 34910320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial.
    Choudhary S; Bisati S; Singh A; Koley S
    Indian J Dermatol; 2013 Nov; 58(6):457-60. PubMed ID: 24249898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study.
    Jerajani H; Janaki C; Kumar S; Phiske M
    Indian J Dermatol; 2013 Jan; 58(1):34-8. PubMed ID: 23372210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis.
    Das A; Sil A; Sarkar TK; Sen A; Chakravorty S; Sengupta M; Das A; Chandra S; Pal S; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2019; 85(3):276-281. PubMed ID: 30409926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle.
    Susilo R; Korting HC; Strauss UP;
    Clin Drug Investig; 2003; 23(6):387-94. PubMed ID: 17535049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis.
    Wannanukul S; Chiabunkana J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S68-71. PubMed ID: 16083165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis.
    Sharma A; Saple DG; Surjushe A; Rao GR; Kura M; Ghosh S; Bolmall C; Baliga V
    Mycoses; 2011 May; 54(3):217-22. PubMed ID: 19925567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study.
    Dakhale GN; Gupta AV; Mukhi JI; Kalikar MV
    Perspect Clin Res; 2021; 12(4):223-228. PubMed ID: 34760651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.